Global Health operates a network of four hospitals under the Medanta brand in Gurugram, Indore, Ranchi and Lucknow. In addition, one hospital is under construction in Patna, and another is planned for development in Noida
The acquisition complements and strengthens Merck’s cardiovascular pipeline
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
A team of experts at Fortis Gurugram conducted 3-dimensional mapping with the help of the new system Carto version 7 to precisely map the source of the arrhythmia. It was detected that the arrhythmia was coming from the conduction system i.e. body’s natural wiring.
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
The pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine
Subscribe To Our Newsletter & Stay Updated
